Wealthspire Advisors (New York)’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,605
| Closed | -$309K | – | 766 |
|
|
2024
Q2 | $309K | Sell |
2,605
-120
| -4% | -$14.3K | ﹤0.01% | 533 |
|
|
2024
Q1 | $290K | Sell |
2,725
-303
| -10% | -$32.3K | ﹤0.01% | 527 |
|
|
2023
Q4 | $301K | Sell |
3,028
-261
| -8% | -$26K | ﹤0.01% | 526 |
|
|
2023
Q3 | $340K | Buy |
3,289
+1,546
| +89% | +$160K | 0.01% | 463 |
|
|
2023
Q2 | $212K | Buy |
1,743
+429
| +33% | +$52.1K | ﹤0.01% | 518 |
|
|
2023
Q1 | $202K | Sell |
1,314
-496
| -27% | -$76.2K | ﹤0.01% | 505 |
|
|
2022
Q4 | $325K | Buy |
+1,810
| New | +$325K | 0.01% | 442 |
|
|
2022
Q2 | – | Sell |
-1,175
| Closed | -$202K | – | 511 |
|
|
2022
Q1 | $202K | Buy |
+1,175
| New | +$202K | ﹤0.01% | 415 |
|
|
2021
Q4 | – | Sell |
-578
| Closed | -$222K | – | 595 |
|
|
2021
Q3 | $222K | Buy |
+578
| New | +$222K | ﹤0.01% | 527 |
|
|
2021
Q2 | – | Sell |
-2,870
| Closed | -$376K | – | 554 |
|
|
2021
Q1 | $376K | Buy |
+2,870
| New | +$376K | 0.01% | 480 |
|